Asia Vaccine Development Leaders Summit 2015
About AVDLS 2015
The outlook of the vaccine industry is one of continued growth and is predicted to reach $35billion by 2015. the Asia vaccine industry is expected to grow at an astonishing rate of 15% from 2009-2017 according to GIA. Vaccine industry in Asian emerging markets such as China and India is contributing the majority of growth for the market thanks to the huge demand for Research and development strategy, Novel partnership model,technology transfer, scaling up, manufacturing technology advancement ,new facilities for multi-products, and also licensing rights for the access to novel vaccines and advanced biotech in Asia.
China, being the world’s largest vaccine producer, is prepared to take on a larger role in the international vaccine market after the recent healthcare reform and the acknowledgement of SFDA (State Food and Drug Administration) by WHO.
A part of our highly successful Clinical Trials series, the event, which attracts over 180 attendees from Global vaccine manufacturers,academic researchers, veterinarians, vaccine policy makers,novel development and manufacturing techonolgy and equipment provider will build upon AVDLS 2015 held in May 20th and 21th in Parkyard Hotel Shanghai ,China and examine latest industrial trends, R&D strategies, partnership models , vaccine development and manufacturing technology advancements in Asia, you will hear the challenges and triumphs of product developers who continue to advance their innovations to combat emerging and infectious diseases. This event promises to provide participants an avenue to meet Asia vaccine industry players, innovative solutions providers and regulatory officials from around the world to discuss, innovate and forge strategic partnerships.
With over 30 speakers and estimation to bring over 180 Vaccine professionals, the key congress topics will cover:
--- Asian Regulation , Industrial Trends, R&D Strategies
--- Novel Vaccines Development: Innovations & Applications
--- Improving Vaccine Therapeutic Efficacy
--- Exploring vaccine R&D Technologies & Manufacturing
--- Cell Culture Technology for Vaccine Manufacturing
--- Designing the Next Generation of Vaccine Adjuvants
--- New building of a multipurpose vaccine production facility
--- Next Generation Vaccines Development and Biotech for Asia
--- Changing State of Veterinary Vaccine R&D in Asia
--- Best practices for GMP, QA/QC, & WHO PQ Review
On behalf of the committee, we sincerely hope primary discussions, topics and invitees would come across your scientific and strategic interests and the whole summit will be consisted of keynote speeches, panel/roundtable discussions, open Q&A sessions, booth and poster exhibition and guided networking sessions for all professionals and management who are working for the Vaccine development and production in Asia.
